Rosenbaum David P. 4
4 · ARDELYX, INC. · Filed Aug 22, 2024
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-08-20$5.86/sh−4,969$29,120→ 351,510 total - Sale
Common Stock
2024-08-20$5.86/sh−2,250$13,186→ 156,252 total(indirect: By Spouse)
Holdings
- 77,592(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]The shares are directly held by the Reporting Person's wife.
- [F3]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.